4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine has been researched along with glutaric acid in 1 studies
| Studies (4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine) | Trials (4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine) | Recent Studies (post-2010) (4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine) | Studies (glutaric acid) | Trials (glutaric acid) | Recent Studies (post-2010) (glutaric acid) |
|---|---|---|---|---|---|
| 9 | 0 | 1 | 553 | 3 | 127 |
| Protein | Taxonomy | 4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine (IC50) | glutaric acid (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 6 | Homo sapiens (human) | 4.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergh, JJ; Castagnoli, N; Mienie, LJ; Pond, SM; Steyn, SJ; Van der Schyf, CJ; Van Staden, E | 1 |
1 other study(ies) available for 4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine and glutaric acid
| Article | Year |
|---|---|
Metabolic defects caused by treatment with the tetrahydropyridine analog of haloperidol (HPTP), in baboons.
Topics: Animals; Dicarboxylic Acids; Electron-Transferring Flavoproteins; Fatty Acid Desaturases; Flavoproteins; Glutarates; Glycine; Haloperidol; Humans; Iron-Sulfur Proteins; Kinetics; Male; Mitochondria; Multienzyme Complexes; Oxidoreductases Acting on CH-NH Group Donors; Oxygen Consumption; Papio | 1997 |